A peptide synthesized by researchers at the University of São Paulo (USP) in Brazil protected human lung cells against infection by SARS-CoV-2 in the laboratory and eliminated the inflammation caused by the virus in mice susceptible to COVID-19. Development of the peptide was inspired by the protein ACE2, the human cell’s natural receptor for SARS-CoV-2.
Medical Xpress – latest medical and health news stories